BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2157601)

  • 1. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal kappa-opioid receptors.
    Quock RM; Best JA; Chen DC; Vaughn LK; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1990 Jan; 175(1):97-100. PubMed ID: 2157601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of central opioid receptor involvement in nitrous oxide analgesia in mice.
    Chen DC; Quock RM
    Anesth Prog; 1990 Jul; 37(4):181-5. PubMed ID: 1965769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of narcotic antagonist drugs upon nitrous oxide analgesia in mice.
    Quock RM; Graczak LM
    Brain Res; 1988 Feb; 440(1):35-41. PubMed ID: 2833991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors.
    Ochi T; Fujii T; Motoyama Y; Goto T
    Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by U-50,488H against beta-chlornaltrexamine antagonism of nitrous oxide antinociception in mice.
    Quock RM; Mueller J
    Brain Res; 1991 May; 549(1):162-4. PubMed ID: 1832578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of nitrous oxide antinociception in mice by intrathecally administered antisera to endogenous opioid peptides.
    Cahill FJ; Ellenberger EA; Mueller JL; Tseng LF; Quock RM
    J Biomed Sci; 2000; 7(4):299-303. PubMed ID: 10895052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptors and acetaminophen (paracetamol).
    Raffa RB; Walker EA; Sterious SN
    Eur J Pharmacol; 2004 Oct; 503(1-3):209-10. PubMed ID: 15496316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord.
    Zhang C; Davies MF; Guo TZ; Maze M
    Anesthesiology; 1999 Nov; 91(5):1401-7. PubMed ID: 10551592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal kappa-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a kappa-selective antagonist.
    Sander HW; Portoghese PS; Gintzler AR
    Brain Res; 1988 Dec; 474(2):343-7. PubMed ID: 2850091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
    Pick CG; Paul D; Pasternak GW
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
    Wu HE; Hung KC; Mizoguchi H; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):647-54. PubMed ID: 11805228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the midbrain.
    Emmanouil DE; Dickens AS; Heckert RW; Ohgami Y; Chung E; Han S; Quock RM
    Eur Neuropsychopharmacol; 2008 Mar; 18(3):194-9. PubMed ID: 17683915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.